๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of nonalcoholic steatohepatitis: Antioxidants or insulin sensitizers?

โœ Scribed by Adams, Leon A.; Angulo, Paul

Book ID
123211719
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
61 KB
Volume
2
Category
Article
ISSN
1542-3565

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Insulin sensitizers in nonalcoholic stea
Insulin sensitizers in nonalcoholic steatohepatitis
โœ Stephen A. Harrison; Steven Schenker; Kenneth Cusi ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 378 KB ๐Ÿ‘ 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Therapeutic trials in nonalcoholic steat
Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
โœ Vlad Ratziu; Stephen Caldwell; Brent A. Neuschwander-Tetri ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 146 KB ๐Ÿ‘ 1 views

Insulin sensitizers are attractive candidate therapies for nonalcoholic steatohepatitis mainly because of the strong association between this disease and insulin resistance. This review provides a critical overview of the mechanisms of action, clinical trial results, and safety issues of metformin a